Results 161 to 170 of about 12,023 (194)

Ceftazidime-Avibactam/Aztreonam Combination for the Treatment of Carbapenem-resistant Klebsiella pneumoniae-induced Osteomyelitis: A Case Series with Review of Literature. [PDF]

J Orthop Case Rep
Gupta A, Chaudhari H, Kumar R, Mishra AK, Aggarwal N, Saran A.   +5 more
europepmc   +1 more source

Suboptimal ceftazidime-avibactam exposure drives sequential <i>bla</i>_KPC mutations and intra-host coexistence of <i>Klebsiella pneumoniae</i> harboring distinct variants leading to persistent infection. [PDF]

Microbiol Spectr
Yang F, Yang W, Zhang J, Tang C, Ding L, Shen S, Zhou Y, Zhao H, Zhou J, Hu F.   +9 more
europepmc   +1 more source

Ceftazidime-avibactam resistance evolution in <i>Pseudomonas aeruginosa</i> and implications for cross-resistance to other novel β-lactams. [PDF]

Antimicrob Agents Chemother
Dorazio AJ, Kline EG, Squires KM, Shah S, Van Tyne D, Wu JY, Pogue JM, Shields RK.   +7 more
europepmc   +1 more source

In vitro activity of aztreonam–avibactam combination against blood culture isolates of Stenotrophomonas maltophilia in Japan before the launch of ceftazidime–avibactam

Microbiology Spectrum
Wataru Aoki, Yoshifumi Uwamino, Yuka Kamoshita, Rika Inose, Mika Nagata, Naoki Hasegawa, Hiromichi Matsushita   +6 more
doaj   +1 more source

Comparative <i>in vitro</i> activity of aztreonam-avibactam and aztreonam plus ceftazidime-avibactam against <i>Stenotrophomonas maltophilia</i> complex. [PDF]

Antimicrob Agents Chemother
Kunz Coyne AJ, Gray R, Gonnabathula P, May ES, Tamma PD, Do A.   +5 more
europepmc   +1 more source

Clinical Characteristics and Outcomes of Bloodstream Infections Caused by Metallo-β-Lactamase-Producing Enterobacterales in Argentina: A Subanalysis of the EMBARCAR Prospective Multicenter Cohort Study. [PDF]

Open Forum Infect Dis
Cordova E, Balbuena JP, Mykietiuk A, Farina J, Gañete M, Scapellato P, Lespada MI, Nannini E, Contreras R, Cunto E, Barcelona L, Pasteran F, Salgueira C, Hojman M, Blanco M, Lopez Alegre H, Cox Fernandez WE, Ezcurra C, Godoy D, Biglia MA, Lopez Furst MJ, Mendez G, Aguirre Rios MF, Altclas J, Sanchez C, Stryjewski ME.   +25 more
europepmc   +1 more source

High <i>in vitro</i> activity of aztreonam/avibactam against NDM-producing Enterobacterales with emerging resistance in <i>Escherichia coli</i> in the United States Mid-Atlantic region. [PDF]

Microbiol Spectr
Eklund E, Maruca T, Kruczynski K, Critchfield H, Murphy R, Keller E, Lee B, Patel A, Klein L, Torpey DA, Myers RA, Campodónico VL.   +11 more
europepmc   +1 more source

Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Karunanidhi A, Singh N, Watkins JV, Smith NM, Zang Y, Shan X, Espinoza G, Li J, Lang Y, Bulitta JB, Bulman ZP.   +10 more
europepmc   +1 more source

Authors' response to comment on evaluation of high dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation. [PDF]

Int J Clin Pharm
Lewis SJ, Bauman AJ, Caiazza OG, Wan N, Payer S, Pauly OG, Shoemaker S.   +6 more
europepmc   +1 more source